13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
SANOFI SA INHABER EO 2 920657 Frankfurt 90,880 26.06.24 17:24:01 -2,170 -2,33% 0,000 0,000 93,000 93,050
REGENERON PHARMAC.DL-,001 881535 Frankfurt 1.006,500 26.06.24 19:05:51 +20,500 +2,08% 0,000 0,000 997,200 986,000

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH